Pya Waltman Capital, LLC Mannkind Corp Transaction History

Pya Waltman Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$2.67 - $4.77 $26,088 - $46,607	-9,771 Reduced 99.43%	56 $0
Q4 2021 Feb 07, 2022	BUY	$4.05 - $5.37 $39,799 - $52,770	9,827 New	9,827 $43,000
Q4 2020 Feb 03, 2021	SELL	$1.79 - $4.04 $17,950 - $40,513	-10,028 Closed	0 $0
Q3 2020 Nov 04, 2020	SELL	$1.56 - $2.08 $135 - $180	-87 Reduced 0.86%	10,028 $19,000
Q4 2019 Feb 13, 2020	BUY	$1.14 - $1.49 $11,531 - $15,071	10,115 New	10,115 $13,000

244

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.57B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Pya Waltman Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pya Waltman Capital, LLC with notifications on news.